(R)-Butaprost (CAS 69648-38-0)

(R)-Butaprost is a synthetic analog of prostaglandin E2, specifically acting as an agonist at the EP2 receptor. This enantiomer has been widely studied for its potent and selective stimulation of this receptor subtype, which leads to elevated intracellular cyclic AMP (cAMP) levels. Activation of the EP2 receptor by (R)-Butaprost is known to induce signaling pathways that promote vasodilation, smooth muscle relaxation, and the suppression of immune cell activation. In research settings, it has been utilized to study the complex roles of EP2-mediated pathways in inflammation and immune responses. Notably, (R)-Butaprost has contributed to uncovering the mechanisms behind the regulation of cytokine production, illustrating how EP2 receptor activation can influence the secretion of pro-inflammatory and anti-inflammatory cytokines. Additionally, its involvement in vascular biology has helped explain EP2′s role in the control of vascular tone and endothelial function. By serving as a valuable tool in prostaglandin research, (R)-Butaprost provides insights into the diverse physiological processes mediated by EP2 receptor signaling, assisting scientists in understanding receptor-specific functions and advancing the knowledge of cellular processes influenced by prostaglandin pathways.